作者
Karl Baumforth, Anna Birgersdotter, Gary M Reynolds, Wenbin Wei, Georgia Kapatai, Joanne R Flavell, Emma Kalk, Karen Piper, Steve Lee, Lee Machado, Kerry Hadley, Anne Sundblad, Jan Sjoberg, Magnus Bjorkholm, Anna A Porwit, Lee-Fah Yap, Soohwang Teo, Richard G Grundy, Lawrence S Young, Ingemar Ernberg, Ciaran BJ Woodman, Paul G Murray
发表日期
2008/7/31
期刊
The American journal of pathology
卷号
173
期号
1
页码范围
195-204
出版商
Elsevier
简介
In ∼50% of patients with Hodgkin's lymphoma (HL), the Epstein-Barr virus (EBV), an oncogenic herpesvirus, is present in tumor cells. After microarray profiling of both HL tumors and cell lines, we found that EBV infection increased the expression of the chemokine CCL20 in both primary Hodgkin and Reed-Sternberg cells and Hodgkin and Reed-Sternberg cell-derived cell lines. Additionally, this up-regulation could be mediated by the EBV nuclear antigen 1 protein. The higher levels of CCL20 in the supernatants of EBV-infected HL cell lines increased the migration of CD4+ lymphocytes that expressed FOXP3, a marker of regulatory T cells (Tregs), which are specialized CD4+ T cells that inhibit effector CD4+ and CD8+ T cells. In HL, an increased number of Tregs is associated with the loss of EBV-specific immunity. Our results identify a mechanism by which EBV can recruit Tregs to the microenvironment of HL by …
引用总数
2008200920102011201220132014201520162017201820192020202120222023202411822181718182114915891813126